BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15466649)

  • 1. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
    Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
    Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
    Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction.
    Matsusaka H; Kinugawa S; Ide T; Matsushima S; Shiomi T; Kubota T; Sunagawa K; Tsutsui H
    J Cardiovasc Pharmacol; 2006 Sep; 48(3):95-102. PubMed ID: 17031262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
    Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
    J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy.
    Stull LB; Leppo MK; Szweda L; Gao WD; Marbán E
    Circ Res; 2004 Nov; 95(10):1005-11. PubMed ID: 15499028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
    Wang S; Fei K; Xu YW; Wang LX; Chen YQ
    Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
    Zhang YL; Zhou SX; Wang MH; Wang JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Hayashi K; Kimata H; Obata K; Matsushita A; Fukata A; Hashimoto K; Noda A; Iwase M; Koike Y; Yokota M; Nagata K
    J Card Fail; 2008 Apr; 14(3):238-44. PubMed ID: 18381188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.